Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > that said, Foofadoo has a great find

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Jul 06, 2020 11:24am

65 Views

Post# 31228696

RE:RE:RE:RE:RE:that said, Foofadoo has a great find

Completed in 2020. When was it started? Teacher gave it a "F" for using the old Prometic name and all the XX's, AAA's.

Best laugh I have had here in the last year.

foofadooo wrote:
The report was completed in 2020 .....it is a 5 year forecast for Renal Kidney Disease and their graph shows Liminal (formerly Prometic) at near 20% of the market!

foof